Linked Life Data

15679762

Source:http://linkedlifedata.com/resource/pubmed/id/15679762

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-1-31
pubmed:abstractText
Mesalazine as the treatment standard for ulcerative colitis can be applied in different galenical preparations.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0269-2813
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
133-40
pubmed:dateRevised
2009-6-26
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis.
pubmed:affiliation
Department of Gastroenterology and Nutrition, Byelorussian Medical Academy Postgraduate Education, Minsk, Republic of Belarus.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't